IXICO plc has completed a placing, subscription and retail offer
IXICO plc has raised US$5 million (£4.05 million) through an over-subscribed placing, subscription and retail offer, issuing 42,621,508 new ordinary shares at 9.5 pence per share, a premium to the price at the time. This important fundraising initiative enables the company to further its pioneering work in neuroscience through advanced imaging and data analytics.
IXICO is a leading medical imaging services provider, specializing in supporting clinical trials for pharmaceutical and biotech companies. With a global network of imaging sites and its custom TrialTracker platform, IXICO offers advanced imaging analytics and digital biomarker services for a variety of neurological diseases, including Alzheimer’s, Huntington’s, Parkinson’s and rare neurological disorders. The company is committed to regulatory compliance and has extensive experience in early-phase clinical development and extended longitudinal studies.
Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised IXICO plc on this transaction.
Prata med transaktionsteamet
Relaterade transaktioner
Banco BPM Vita S.p.A. has launched a voluntary public tender offer for Anima Holding S.p.A.
Banco BPM Vita S.p.A. has initiated a voluntary public tender offer for the shares of Anima Holding S.p.A.
Lär dig merTerra Holding S.r.l. has launched a voluntary public tender offer for Gibus S.p.A.
Terra Holding S.r.l. has initiated a voluntary public tender offer for the shares of Gibus S.p.A.
Lär dig merPharma-Skan & Skan-Medic have been acquired by Brygge Partners
Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.
Lär dig mer